Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: GlaxoSmithKline Research & Development Limited
August 29, 2025
GlaxoSmithKline Research & Development Limited
Orphan Drug Designation
FDA orphan drug designation: treatment of autosomal dominant polycystic kidney disease (ADPKD)
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
